Literature DB >> 21360409

The effect of female hormones upon urate transport systems in the mouse kidney.

Yuichi Takiue1, Makoto Hosoyamada, Masaki Kimura, Hidetsugu Saito.   

Abstract

Increased levels of serum urate in postmenopausal women are thought to be caused by a change in renal urate elimination associated with the loss of female hormones. In this study, we investigated the regulation of renal urate transporter expression by female hormones using ovariectomized mice with or without hormone replacement. Estradiol suppressed the protein levels of urate reabsorptive transporters urate transporter 1 and glucose transporter 9 (Urat1 and Glut9), and that of urate efflux transporter ATP-binding cassette sub-family G member 2 (Abcg2). Progesterone suppressed protein levels of sodium-coupled monocarboxylate transporter 1 (Smct1). However, neither estradiol nor progesterone influenced the respective levels of mRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360409     DOI: 10.1080/15257770.2010.551645

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  30 in total

1.  The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.

Authors:  Youssef M Roman
Journal:  Hawaii J Med Public Health       Date:  2019-02

Review 2.  Gout: a review of nonmodifiable and modifiable risk factors.

Authors:  Lindsey A MacFarlane; Seoyoung C Kim
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

3.  [Aromatase inhibitors combined with growth hormone in treatment of adolescent boys with short stature].

Authors:  Yuanmei Kong; Hong Chen; Li Liang; Maoni Zheng; Yanlan Fang; Chunlin Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

4.  Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses.

Authors:  Kazuma Mori; Masato Furuhashi; Marenao Tanaka; Yukimura Higashiura; Masayuki Koyama; Nagisa Hanawa; Hirofumi Ohnishi
Journal:  Hypertens Res       Date:  2021-11-30       Impact factor: 3.872

Review 5.  Time to target uric acid to retard CKD progression.

Authors:  Takanori Kumagai; Tatsuru Ota; Yoshifuru Tamura; Wen Xiu Chang; Shigeru Shibata; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

6.  The Serum Uric Acid Level Is Related to the More Severe Renal Histopathology of Female IgA Nephropathy Patients.

Authors:  Won Jung Choi; Yu A Hong; Ji Won Min; Eun Sil Koh; Hyung Duk Kim; Tae Hyun Ban; Young Soo Kim; Yong Kyun Kim; Seok Joon Shin; Seok Young Kim; Young Ok Kim; Chul Woo Yang; Yoon-Kyung Chang
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

7.  Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study.

Authors:  Eiichiro Kanda; Toshitaka Muneyuki; Yoshihiko Kanno; Kaname Suwa; Kei Nakajima
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.

Authors:  Olha Hurba; Andrea Mancikova; Vladimir Krylov; Marketa Pavlikova; Karel Pavelka; Blanka Stibůrková
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 9.  Urate Transporters in the Kidney: What Clinicians Need to Know.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2021-06-30

10.  Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.

Authors:  Yasuyuki Nagasawa; Ryohei Yamamoto; Tatsuya Shoji; Maki Shinzawa; Yukiko Hasuike; Katsuyuki Nagatoya; Atsushi Yamauchi; Terumasa Hayashi; Takayuki Kuragano; Toshiki Moriyama; Yoshitaka Isaka; Takeshi Nakanishi
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.